Please use this identifier to cite or link to this item: https://ktisis.cut.ac.cy/handle/10488/3674
Title: Allergic Rhinitis and Its Impact on Asthma (ARIA): Achievements in 10 Years and Future Needs
Authors: Zuberbier, Torsten 
Bousquet, Jean 
Schunemann, Holger J. 
Samolinski, Boleslaw K. 
Demoly, Pascal 
Baena-Cagnani, Carlos Eduardo 
Bachert, Claus 
Bonini, Sergio 
Boulet, Louis Philippe 
Bousquet, Philippe Jean 
Brozek, Jan L. 
Cox, Linda S. 
Durham, Stephen R. 
Bindslev-Jensen, Carsten 
Mohammad, Y. 
Spicak, Vaclav 
Akdis, Cezmi A. 
Gotua, Maia A. 
Romano, Antonino 
Papadopoulos, Nikolaos G. 
Kuna, Piotr 
Kalayci, Omer 
Masjedi, Mohammad Reza 
Ansotegui, Ignacio Javier 
Ozdemir, Cevdet 
Kull, Inger 
Price, David B. 
Larenas-Linnemann, Desiree Erlinda Sophia 
Lemiere, Catherine 
Okamoto, Yoshitaka 
Dolen, William K. 
Rosado-Pinto, Jose E. 
Sheikh, Aziz A. 
Just, Jocelyne 
Schmid-Grendelmeier, Peter D. 
Lockey, Richard Funk 
Agache, Ioana O. 
Zidarn, Mihaela 
Tremblay, Y. 
Chivato Perez, T. 
Braido, Fulvio 
Mendez, Nora Hidalgo Segura 
Keil, Thomas Oskar Philipp 
Bush, Andrew P. 
Mahboub, Bassam Hassan Saleh Hassan 
Nizankowska-Mogilnicka, Ewa 
Todo-Bom, Ana Mría 
Beghe, Bianca 
Bennoor, K. Saifuddin 
Yusuf, Osman Mohammad 
Khaltaev, Nikolai G. 
Viegi, Giovanni 
Custovic, Adnan 
Pigearias, Bernard 
Fiocchi, Alessandro 
Muraro, Antonella 
Haahtela, Tari M K 
Ryan, Dermot P. 
Melen, Erik 
Valiulis, Arunas 
Williams, Dennis M. 
Sisul, Juan Carlos 
Van Wijk, Roy Gerth 
Sunyer, J. Jordi 
Popov, Todor A. 
Hourihane, Jonathan O Brien 
Naclerio, Robert M. 
Simons, F. Estelle R 
Zernotti, Mario Emilio 
Rosenwasser, Lanny J. 
Ben Kheder, Ali 
Lipworth, Brian Jonathon 
Chkhartishvili, E. V. 
Baiardini, Ilaria 
Calvo, Mario A. 
Valero, Antonio Luis 
Douagui, H. 
Nekam, Kristof 
Passalacqua, Giovanni 
Ouedraogo, S. 
Costa, David J. 
Fonseca, Joao Almeida 
Dykewicz, M. S. 
Sooronbaev, Talantbek M. 
Pawankar, Ruby U. 
Carr, Warner W. 
Roman-Rodriguez, Miguel 
Park, Haesim 
Cesario, Alfredo 
Guzman, Maria Antonieta 
Deleanu, Diana 
Bel, Elisabeth H D 
Bateman, Eric D. 
Humbert, Marc 
Maurer, Marcus 
Blaiss, Michael S. 
Fukuda, T. 
De Blay, Frederic 
Spranger, O. 
Niggemann, Bodo 
Vichyanond, Pakit 
Mihaltan, Florin Dumitru 
Denburg, Judah A. 
Gonzalez-Diaz, Sandra Nora 
Lieberman, Phil L. 
Chen, Yuzhi 
Nafti, Salim 
Devillier, Philippe H. 
Gereda, Jose E. 
Rottem, Menachem 
Dubakiene, Ruta 
El-Meziane, Abdelatif 
Camargos, Paulo Augusto Moreira 
Beji, Majed 
Valeyre, Dominique 
O'Hehir, Robyn E. 
Darsow, Ulf 
Morais-Almeida, Mario A. 
Bouchard, Jacques 
Kvedariene, Violeta 
Lodrup Carlsen, Karin Cecilie 
Stoloff, Stuart W. 
Ciprandi, Giorgio 
Caraballo, Luis R. 
Brightling, Christopher Edward E 
Palkonen, Susanna 
Pali-Scholl, Isabella 
Sole, Dirceu Luiz Pereira 
Hourihane, Jonathan O Brien 
Fokkens, Wytske Johanna 
Vandenplas, Olivier 
Fletcher, Monica J. 
Merk, H. 
Canonica, Giorgio Walter 
Ivancevich, Juan Carlos 
Toskala, Elina M. 
Kowalski, M. L. 
Berrissoul, F. 
Boner, Attilio Loris 
Roberts, Richard G. 
Emuzyte, Regina 
Casale, Thomas B. 
Makela, Mika J. 
Pohl, Wolfgang R. 
Kaliner, Michael A. 
Potter, Paul C. 
Ivancevich, Juan Carlos 
Koppelman, Gerard H. 
Khayat, Georges 
Le, Lan Thi Tuyet 
Stein, Renato Tetelbom 
Horak, Friedrich 
Bergmann, Karl Ch 
Zhong, Nanshan 
Neou, Angelos 
Keith, Paul Kevin 
Orru, M. P. 
Panzner, Petr 
Ohta, Ken 
Ait-Khaled, Nadia 
Chiriac, Anca Mirela 
Koffi N'Goran, B. 
Szczeklik, Andrzej J. 
Andrianarisoa, A. O C 
Rogala, Barbara K. 
Didi, T. 
Van Weel, Chris 
Namazova-Baranova, Leyla S. 
Grouse, Lawrence 
Wickman, Magnus 
Hellquist-Dahl, B. 
Scadding, Glenis Kathleen 
Dahl, Ronald 
Ratomaharo, J. 
Dokic, Dejan 
Nyembue, Tshipukane Dieudonne 
Togias, Alkis G. 
Wang, Deyun 
Mazon, Angel 
El-Gamal, Yehia M. 
Zar, Heather J. 
Wohrl, Stefan 
Kaliner, Michael A. 
Sanchez-Borges, Mario 
Martin, Francisco Jesus 
Yorgancioglu, Arzu 
Bieber, Thomas 
Caballero, F. M. 
Rabe, Klaus Friedrich 
Wright, John P. 
Okubo, Kimihiro 
Ring, Johannes 
Yawn, Barbara P. 
Hellings, Peter Wim 
Cepeda, Alfonso M. 
Postma, Dirkje Sjoukje 
Valenta, Rudolf 
Gamkrelidze, Amiran G. 
Van Cauwenberge, Paul B. 
Li, Jing 
Carlsen, Kai Hakon 
Mavale-Manuel, S. 
Valovirta, Erkka Juhani 
Chavannes, Niels H. 
Reitamo, Sakari J. 
Meltzer, Eli O. 
Kim, Youyoung 
Mullol, Joaquim 
Adachi, Mitsuru 
Cruz, Alvaro Augusto Souza 
Marshall, Gailen D. 
Yiallouros, Panayiotis K. 
Bedbrook, Anna 
Aberer, Werner 
Annesi-Maesano, Isabella 
Martinez, Fernando 
Calderon, Moises A. 
Keywords: Quality-of-life;Allergy;Immunology;World-health-organization;Persistent types;Controlled-trial;Primary-care
Category: Clinical Medicine
Field: Medical and Health Sciences
Issue Date: 2012
Publisher: Mosby-Elsevier
Source: Journal of Allergy and Clinical Immunology, 2012, vol. 130, no.5, pp. 1049-1062
Journal: Allergy: European Journal of Allergy & Clinical Immunology 
Abstract: Allergic rhinitis (AR) and asthma represent global health problems for all age groups. Asthma and rhinitis frequently coexist in the same subjects. Allergic Rhinitis and its Impact on Asthma (ARIA) was initiated during a World Health Organization workshop in 1999 (published in 2001). ARIA has reclassified ARas mild/moderate-severe and intermittent/persistent. This classification closely reflects patients' needs and underlines the close relationship between rhinitis and asthma. Patients, clinicians, and other health care professionals are confronted with various treatment choices for the management of AR. This contributes to considerable variation in clinical practice, and worldwide, patients, clinicians, and other health care professionals are faced with uncertainty about the relative merits and downsides of the various treatment options. In its 2010 Revision, ARIA developed clinical practice guidelines for the management of AR and asthma comorbidities based on the Grading of Recommendation, Assessment, Development and Evaluation (GRADE) system. ARIA is disseminated and implemented in more than 50 countries of the world. Ten years after the publication of the ARIAWorld Health Organization workshop report, it is important to make a summary of its achievements and identify the still unmet clinical, research, and implementation needs to strengthen the 2011 European Union Priority on allergy and asthma in children. (J Allergy Clin Immunol 2012,130:1049-62.)
Description: J. Bousquet has received honoraria from Stallergenes, Actelion, Almirall, AstraZeneca, Chiesi, GlaxoSmithKline, Merck, Novartis, OM Pharma, Sanofi, Teva, and Uriach. P. Demoly is a speaker for and on the advisory board of Stallergenes and ALK-Abello, is a consultant for Therabel and Crucell, is a speaker for Merck/Schering- Plough, AstraZeneca, and GlaxoSmithKline, has received research support from Stallergenes and ALK-Abello, and is the Vice President of the European Academy of Allergy and Clinical Immunology (EAACI). S. Bonini has a scientific board member and speaker at Symposia sponsored by A. Menarini, MS&D, Novartis, Nycomed/Takeda, PHADIA/Thermo Fischer, and Stallergenes and is a member of the LIBRA (Italian Guidelines for Asthma, Rhinitis, and COPD) executive board. L. P. Boulet is on the advisory boards for AstraZeneca, GlaxoSmithKline, Merck Frosst, and Novartis, has received lecture fees from 3M, AstraZeneca, GlaxoSmithKline, Merck Frosst, and Novartis, has received research support from Altair, Amgen, Asmacure, AstraZeneca, Boehringer-Ingelheim, Genentech, GlaxoSmithKline, Pharmaxis, Schering, Wyeth, and Merck Frosst, is chair for the Canadian Thoracic Society Respiratory Guidelines Committee and the Global Initiative for Asthma (GINA) Guidelines and Implementation Committee, is an organizational holder for the Laval University Chair on Knowledge Transfer, Prevention and Education in Respiratory and Cardiovascular Health, and is a member of the Knowledge Translation Canada. T. B. Casale is on the Stallergenes advisory board, is a consultant for Roche has received research support from Stallergenes and Roche, and is Executive Vice President for the American Academy of Allergy, Asthma & Immunology (AAAAI). A. A. Cruz is an advisor and lecturer for Merck and Mantecorp, is a lecturer for GlaxoSmithKline, Novartis, Chiesi, and Aventis, has received an educational grant from Ache, and has received research support from the Brazilian Research Council, Fundacao de Amparo a Pesquisa da Bahia, and GlaxoSmithKline. W. J. Fokkens has received research support from GlaxoSmithKline and provided legal consultation/expert witness testimony for Stallergenes. J. A. Fonseca has received lecture and consulting fees from Merck has received research support from the Fundacao Ciencia e Tecnologia and is Vice President of the Sociedade Portuguesa de Alergologia e Immunologia Clinica. L. Grouse has received funds from Novartis for personal services. T. Haahtela has received lecture fees from Abdi Ibrahim, GlaxoSmithKline, MSD, and OrionPharma and has received research support from Stallergenes. K. C. Lodrup Carlsen has received research support from MeDALL EU. R. Naclerio is on the speaker's bureau for Merck and Sunovion, is a consultant for Teva, Kalypsys, and Regeneron, and has received research support from Nasonebs, GlaxoSmithKline, Merck, and McNeal. K. Ohta has received lecture honoraria from MSD, Novartis, and GlaxoSmithKline. S. Palkonen's employer received grants from Novartis, GlaxoSmithKline, Boehringer-Ingelheim, Pfizer, Chiesi, ALK-Abello , Stallergenes, Nycomed, AstraZeneca, and Air Liquid Healthcare. N. G. Papadopoulos has received honoraria from Merck, AllergoPharma, Abbott, and Uriach. D.Price has received consultancy fees from Merck, Mundipharma, Novartis, GlaxoSmithKline, Almirall, Chiesi, Kyorin, and Teva, has received consultancy fees and grants from Pfizer, AstraZeneca, and Boehringer-Ingelheim, has received research support from the UK National Health Service, Aerocrine, and Nycomed, holds shares in AKL Ltd, and is director of Research in Real Life Ltd. D. Ryan is a consultant for Uriach and is Allergy Lead for the International Primary Care Respiratory Group. F. E. R. Simons is on the Rupatadine Medical Advisory Board. D. Williams's spouse is employed by GlaxoSmithKline. A. Yorgancioglu has received honoraria from MSD, GlaxoSmithKline, and Novartis and has received research support from Chiesi. O. M. Yosuf has received honoraria from and is director and chair of research for the International Primary Care Respiratory Group. C. A. Akdis has received research support from Novartis, PREDICTA, Swiss National Science Foundation, MeDALL, the Global Allergy and Asthma European Network (GA <SUP>2</SUP>LEN), and the Christine Kuthe Center for Allergy Research and Education, has provided legal consultation/expert witness testimony on the topics of Actellion Th2-specific receptors, Aventis T-cell and B-cell regulation, Stallergenes allergen-specific immunotherapy, and Allergopharma allergen-specific immunotherapy, is a Fellow and interest group member of the AAAAI, is president of the EAACI, and is a GA <SUP>2</SUP>LEN ex-com memberWPleader. I. J. Ansotegui has received consulting fees and honoraria from Faes Farma and Bial, has received consulting fees from Johnson & Johnson and Sanofi, and has received honoraria from AstraZeneca. E. D. Bateman is a consultant for and on the advisory board of Almirall, is on the advisory board of Forest, Novartis, Napp Pharma, and Actelion, has received lecture and consultancy fees and grants and is on the advisory board for Boehringer Ingelheim, has received lecture fees and is on the advisory board for GlaxoSmithKline, Nycomed, and AstraZeneca, is a consultant for ALK-Abello, and is the GINA chair of board. E. H. Bel has received research support from GlaxoSmithKline, Novartis, and Innovative Medicine Initiative (EU). M. S. Blaiss is a speaker for GlaxoSmithKline, Merck, AstraZeneca, Nycomed, Sunovion, and Genentech, is a consultant for Alcon, ISTA, Allergan, Proctor & Gamble, and Pfizer, has received research support from GlaxoSmithKline, and is HAD treasurer. M. A. Calderon is a speaker for ALK-Abello, Merck, and STG. K. H. Carlsen has received research support from Helse Sor-Ost RHF (Southern and Eastern Norway Regional Health Authority). W. Carr is a consultant for and has received research support from MEDA, Alcon, and ISTA. A. M. Cepeda is a speaker for MSD, AstraZeneca, and Novartis and has received research support from Novartis and Universidad Metropolitana. L. Cox is a speaker for Thermo-Fisher and ISTA and has received research support from Stallergenes and Teva. A. Custovic has received lecture fees from GlaxoSmithKline, Thermo-Fisher, MSD, and Airsonett, is on the advisory board for Novartis, and has received research support from the Medical Research Council and Moulton Charitable Trust. R. Dahl has received lecture fees from ALK-Abello and MSD, has received research support from ALK-Abello and Stallergenes, and is chair of the Danish Respiratory Society. U. Darsow is a consultant for Benoard. F. De Blay has received research support from Stallergenes, ALK-Abello, Novartis, GlaxoSmithKline, AB Science, and Amgen. J. A.Denburg has received research support from the Canadian Institutes for Health Research and AllerGen NCE. P. Devillier has received consultancy fees and honoraria from Stallergenes and has received consultancy fees from Merck/Schering-Plough, GlaxoSmithKline, and AstraZeneca. S. R. Durham is a consultant and speaker for ALK-Abello and Merck, is a speaker for GlaxoSmithKline, has received consultancy fees from Boehringer Ingelheim and Circassia, has received research support from ALK-Abello and Novartis, has provided legal consultation/expert witness testimony on the topic of topical corticosteroids and antihistamines in allergic rhinitis is on the Immune Tolerance Network/National Institute of Allergy and Infectious Diseases (NIAID) steering committee, and is on the British Society for Allergy and Clinical Immunology standards of care committee. M. S. Dykewicz is a consultant for Merck, is on the AAAAI Board of Directors, Needs Assessment Committee, Rhinitis/Sinusitis/Ocular Diseases Committee, and Web Site Oversight Committee, and is on the American College of Allergy, Asthma & Immunology (ACAAI) Program Directors Advisory Committee (chair), Annual Program Planning Committee, Publications Committee, Rhinitis-Sinusitis Committee, Occupational Health Committee, Ocular Allergy Committee. A. Fiocchi has received research support from Stallergenes. S. Gonzalez Diaz is a speaker for GlaxoSmithKline, MSD, and Takeda and has received research support from the University Hospital and Medical School of Universidad Autonoma de Nuevo Leon, Mexico. M. Gotua has received honoraria from GlaxoSmithKline and AstraZeneca. J. O'B. Hourihane has received research support from the Children's Research Foundation (Ireland), Danone, the Food Standards Agency (United Kingdom), and Stallergenes, in addition, his employer, University College Cork, holds a patent on challenge outcome predictor software. M. Humbert has received consultancy and lecture fees from AstraZeneca, GlaxoSmithKline, Novartis, Pfizer, Stallergenes, and Teva. J. C. Ivancevich is on the Faes Farma advisory board, is speaker for Laboratorios Casasco Argentina, and is Web editor for the World Allergy Organization and Interasma. O. Kalayci was the Uriach Pharma chairperson at the company sponsor symposium. M. A. Kaliner is a consultant for Ista and Alcon, has received research support from multiple allergy and asthma companies, and has provided legal consultation/expert witness testimony for Alcon. T. Keil has received research support from the European Union (EU) and DTG. P. K. Keith is a speaker for and has received research support from GlaxoSmithKline and Merck. B. Koffi N'Goran is a speaker for AstraZeneca and GlaxoSmithKline. G. H. Koppelman has received research support from the Netherlands Asthma Foundation and MeDALL. D. E. Larenas-Linnemann has received a speaker's fee and travel grant from Merck-Sharp-Dohme, Mexico, has received a speaker's fee from AstraZeneca, has received travel grants from Allerquim Mexico, ALK-Abello, and Stallergenes, has received research support from Allerquim Mexico, ALK-Abello, Stallergenes, and Greer Laboratories, and is chair of the IT committee for the AAAAI and Mexican College of Clinical Immunology and Allergy. L. T. Le has received honoraria from GlaxoSmithKline and AstraZeneca, has received research support and honoraria from MSD, and is chair of the Respiratory Society of Ho Chi Minh City, Vietnam. C. Lemiere is on the AstraZeneca advisory board. P. Lieberman is an advisor for the Allergy Foundation of America. B.Lipworth has provided legal consultation/expert witness testimony for Nycomed on the topic of nasal ciclesonide. B. Mahboub is employed by the Dubai Health Authority and the University of Sharjah. F. D. Martinez is a consultant for MedImmune and has received lecture honorarium and travel fees from Abbott. E. O. Meltzer is a consultant and on the advisory board for Alcon, AstraZeneca, Bausch + Lomb, Dey, Forest, Ista, Johnson & Johnson, Meda, Merck, ONO Pharma, OptiNose, Proctor& Gamble, Rady Children's Hospital, Rigel, Sanofi Aventis, Sepracor, Stallergenes, Teva, Alexza, Boehringer Ingelheim, Kalypsys, and Sunovion, is a speaker for the AAAAI, Alcon, Allergists for Israel, Dey, Florida Allergy Asthma Immunol Society, Ista, Sepracor, Teva, Merck, and Sunovion, has received research support from Amgen, Apotex, HRA, MedImmune, Schering-Plough, Alcon, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Proctor & Gamble, Sunovion (Sepracor), and Teva, has provided legal consultation/expert witness testimony for Aventis Pharmaceuticals and Sanofi Aventis in the USLLC v. Barr Laboratories Fexofenadine Litigation, and is a Fellow of the AAAAI, ACAAI, and World Allergy Organization (WAO). H. Merk has received research support from Phadia and has provided legal consultation/expert witness testimony for Novartis and ALK-Abello. F. Mihaltan has received consulting fees and honoraria from AstraZeneca, GlaxoSmithKline, MSD, Novartis, Nycomed, Boehringer Ingelheim, Servier, Sanofi, Pfizer, CSC Johnson&Johnson, Oxygen Plus, and New Medics. S. Nafti has received research support from the European Respiratory Society and the Societe de Pneumologie de Langue Francaise Asthma and has provided legal consultation/expert witness testimony for GlaxoSmithKline on the topics of asthma and chronic obstructive pulmonary disease. Y. Okamoto is a medical advisory for Taibo Pharmaceutical Co, Ono Pharmaceutical Co, and Meiji Nyugyo Co and has received research support from the Ministry of Health, Welfare, and Labor. D. S. Postma has received consultancy fees from Nycomed, GlaxoSmithKline, AstraZeneca, and Chiesi. K. F. Rabe has received research support from Altana, Novartis, AstraZeneca, and MSD and has provided legal consultation/expert witness testimony for AstraZeneca, Chiesi, Novartis, MSD, and GlaxoSmithKline. J. Ring has received research support from ALK-Abello, Allergopharma, Almirall-Hermal, Astellas, Bencard, Biogen-Idec, Gladerma, GlaxoSmithKline, Leo, MSD, Novartis, Phadia, PLS Design, and Stallergenes. R. Roberts is president of the World Organization of Family Doctors and the American Academy of Family Physicians Foundation and is Vice Chair of the Interstate Postgraduate Medical Association. B. Rogala has received lecture fees from Takeda, Nycomed, Teva, UCB, and Chiesi and is on the advisory board for MSD and AstraZeneca. G. K. Scadding has received research support from and is a speaker for ALK-Abello and GlaxoSmithKline, is on the Uriach advisory board, and is a speaker for Merck. A. Sheikh has received consultancy fees from Phadia and NAPP and is a Royal College of GPs Clinical Champion in Allergy. S. W. Stoloff is a consultant and on the advisory board for Teva and is a consultant for Aerocrine, Merck, and Sunovion. B. P. Yawn has received research support from the Agency for Healthcare Research and Quality (AHRQ) and the National Heart, Lung, and Blood Institute (NHLBI). T.Zuberbier has received consultancy fees, honoraria, and/or research support from AnseII, Bayer Schering, OST, Fujisawa, IHAL, Henkel, Kryolan, Leti, MSO, Novartis, Procter and Gamble, Sanofi-Aventis, Schering-Plough, Stallergenes, and UCB, is on the Scientific Advisory Board for the German Society for Allergy and Clinical Immunology, is on the Expert Commission Novel Food'' of the German Federal Ministry of Consumer Protection, is Head of the European Centre for Allergy Research Foundation (ECARF), is a Committee member of the World Health Organization (WHO) Initiative Allergic Rhinitis and its Impact on Asthma (ARIA), is a Member or the WAO Communications Council, and is Secretary General of GA 2 LEN. The rest of the authors declare that they have no relevant conflicts of interest.
ISSN: 0091-6749
DOI: 10.1016/j.jaci.2012.07.053
Collaboration : Hospital Clinic Barcelona
University Hospitals Leuven
World Health Organization
University of Medicine and Pharmacy
University of Manchester
Karolinska University Hospital
Allergy Centre Vienna West
George Washington University
Federal University of Sao Joao del-Rei
EPAR UMR-S UPMC
Tishreen University
University of California
University of South Florida College of Medicine
Universitat Pompeu Fabra
Medical University of Lodz
Hospital Quiron Bizkaia
University of Athens
Institute of Translational Pharmacology-CNR
Korea Asthma Allergy Foundation
Complesso Integrato Columbus
University of St Andrews
Coimbra University Hospital
University of Missouri-Kansas City
Helsinki University Hospital
A.I.R. Khmer Association
Hopital Arnaud de Villeneuve
University of Amsterdam
International Union Against Tuberculosis and Lung Diseases
University Hospital Zurich
Wake Forest University
Institute of Pneumology Marius Nasta
GARD/ARIA Coordinator
Centre for Research in Environmental Epidemiology
University of Cartagena
University of Manitoba
Ain Shams University
Emek Medical Center
Charite-University Medicine Berlin
Celal Bayar University
IRCCS
University of Turku
Mustapha Hospital
University Medical Center
Global Allergy and Asthma Patient Platform
McMaster University
University of Montreal
Technische Universität München
Georgia Health Sciences University
Pontifícia Universidade Catolica
Center of Public Health and Quality Improvement
EPAR U707 INSERM
University of Groningen
Hospital da Luz
Centre Hospitalier Universitaire Pediatrique Charles de Gaulle
Chiba University Hospital
Southern California Research
Leiden University
IB-Salut Balearic Health Service
Leiden University
Charite-University Medicine Berlin
Sachs Childrens Hospital
University of Amsterdam
Swiss Institute of Allergy and Asthma Research
CESP Centre for Research in Epidemiology and Population Health
Del Salvador University
Eduardo Mondlane University
Nippon Medical School
Marmara University
Public Hospital Medical Service
Charles University
University of Oslo
Universite Laval
Universidad Austral de Chile
CNR Institute
Centre of Respiratory Diseases and Allergy
Dokkyo Medical University
University of Genoa
Centro Medico-Docente La Trinidad
Creighton University
Hopital Foch
University of Chicago
Hospital Medica Sur
Center for Asthma Research and Education
University of North Carolina
National Centre Cardiology and Internal Medicine
University of Leicester
Royal Brompton Hospital
Transylvania University
Universitaire de Beni-Messous
Catholic University of Louvain
Montpellier I University
Ajou University School of Medicine
Imperial College London
Erasmus University Rotterdam
Catholic University
University of Washington
Shahid Beheshti University
Kinshasa University
Centre for Research in Environmental Epidemiology
National Institute of Diseases of Chest and Hospital
University College London
National Cooperative Group of Pediatric Research on Asthma
Hοpital Arnaud de Villeneuve
Monash University
University of Southampton
Catholic University
Childrens Hospital La Fe
Centre Hospitalier de la Region dAnnecy
Showa University
Immunoallergia Respiratoria Clínica i Experimental
Aarhus University
Sociedad Paraguaya de Alergia Asma e Inmunología
Karolinska Institutet
Karolinska Institutet
University of Padua
Jagiellonian University
Centre Hospitalo-Universitaire de la Rabta
Melloni Hospital
Floridsdorf Allergy Centre
University of Cape Town
Nippon Medical School
Medical University of Graz
Siriraj Hospital
Porto University
University of Aberdeen
Georgian National University Medical Center
Center of Allergy and Immunology
Federal University of Sao Paulo
National Medical Center
Jagiellonian University
Municipal Institute of Medical Research
CUF-Descobertas Hospital
University of Wisconsin
Societe de Pneumologie de Langue Francaise
Nova Southeastern University
Centro Medico Nacional Siglo XXI
Association Franco-Vietnamienne de Pneumologie
Academic Medical Center
Universite Paris
University of Arizona
Medical University of Vienna
Allergy and Asthma Institute
Centre Hospitalier Universitaire
University of Nuevo Leon
Centro Medico-Docente La Trinidad
University of Sharjah
Federal University of Bahia
McMaster University
University of Tennessee
Universite Paris
University of Nevada
University Ss. Cyril and Methodius
Helsinki University Hospital
Teikyo University
University of Verona
Medical University of Lodz
Hospital of the Hospitaller Brothers in Buda
Medical University of Silesia
Hacettepe University
Scientific Center for Childrens Health RAMS
University of Dundee
Vilnius University
School Medicine CEU San Pablo
Ghent University
Universite Paris
Education for Health
University Hospital of Strasbourg
CIBER Epidemiologia y Salud Publica
University of Medicine and Pharmacy
National Institute of Allergy and Infectious Diseases
Vilnius University
Azienda Ospedaliera Universitaria San Martino
Hopital A Mami
Radboud University Nijmegen Medical Centre
Czech Initiative for Asthma
Childrens Hospital of Philadelphia
University of Edinburgh
University of Mississippi Medical Center
Aachen University
Terveystalo Turku
Cyprus University of Technology
University of Groningen
European Federation of Allergy and Airways Diseases Patients Associations
Clinical Hospital University of Chile
Odense University Hospital
First Affiliated Hospital of Guangzhou Medical College
Universite Laval
Alexanders University Hospital
Karl Landsteiner Institute of Experimental and Clinical Pneumology
Woodbrook Medical Centre
Universite Saint-Joseph
University of Cape Town
Second University of Naples
University of Veterinary Medicine Vienna
Medical University of Warsaw
Clinica Ricardo Palma
Metropolitan University Barranquilla
Hopital Prive dAthis-Mons
Seoul National University
University College Cork
University of Modena and Reggio Emilia
Rights: © 2012 American Academy of Allergy, Asthma & Immunology
Type: Article
Appears in Collections:Άρθρα/Articles

CORE Recommender
Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.